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Whether β1 integrin ectodomains visit conformational states sim-
ilarly to β2 and β3 integrins has not been characterized. Further-
more, despite a wealth of activating and inhibitory antibodies to
β1 integrins, the conformational states that these antibodies sta-
bilize, and the relation of these conformations to function, remain
incompletely characterized. Using negative-stain electron microscopy,
we show that the integrin α5β1 ectodomain adopts extended-closed
and extended-open conformations as well as a bent conformation.
Antibodies SNAKA51, 8E3, N29, and 9EG7 bind to different domains
in the α5 or β1 legs, activate, and stabilize extended ectodomain
conformations. Antibodies 12G10 and HUTS-4 bind to the β1 βI do-
main and hybrid domains, respectively, activate, and stabilize the
open headpiece conformation. Antibody TS2/16 binds a similar epi-
tope as 12G10, activates, and appears to stabilize an open βI domain
conformation without requiring extension or hybrid domain swing-
out. mAb13 and SG/19 bind to the βI domain and βI–hybrid domain
interface, respectively, inhibit, and stabilize the closed conformation
of the headpiece. The effects of the antibodies on cell adhesion to
fibronectin substrates suggest that the extended-open conformation
of α5β1 is adhesive and that the extended-closed and bent-closed
conformations are nonadhesive. The functional effects and binding
sites of antibodies and fibronectin were consistent with their ability
in binding to α5β1 on cell surfaces to cross-enhance or inhibit one
another by competitive or noncompetitive (allosteric) mechanisms.
Integrins comprise a family of 24 adhesion receptors that trans-mit bidirectional signals across the cell membrane (1). Integrin
α- and β-subunits are both type I transmembrane glycopro-
teins, with a large N-terminal extracellular domain, a single-
span transmembrane domain, and usually a short C-terminal
cytoplasmic domain. β2 and β3 integrins adopt three global con-
formational states: bent-closed, extended-closed, and extended-
open (Fig. 1A) (2–10). With β2 and β3 integrins, high concentrations
of ligands induce the extended-open conformation of intact integrin
and ectodomain preparations—and the open conformation of
headpiece preparations—showing that the open conformation has
higher affinity than closed conformations (7, 10–12). Electron
microscopy (EM) studies and cell-surface affinity measurements
with αXβ2 and αLβ2 integrins and conformation-specific Fabs show
that the bent-closed and extended-closed conformations have
low affinity for ligand whereas the extended-open conformation
has high affinity for ligand (8, 9, 13).
We know less about β1 integrin conformational states. The β1
subunit associates with 12 integrin α-subunits, including those that
contain or lack αI domains, to form by far the largest and most
diverse integrin subfamily. β1 integrins recognize ligands including
collagens, laminins, ligands with Arg-Gly-Asp (RGD) motifs in-
cluding fibronectin, and Ig superfamily members including cell-
adhesion molecules (1). Cells localized in tissues basally adhere
through β1 integrins to the extracellular matrix. In contrast, β2 and
β3 integrins are commonly expressed on cells that circulate in the
bloodstream in a state in which these integrins are nonadhesive.
Only upon cellular activation in the bloodstream do β2 integrins on
leukocytes or β3 integrins on platelets become active and bind their
ligands (1). A common discussion point among integrin biologists is
the concept that β1 integrins may be regulated differently from β2
and β3 integrins. One proposal is that β1 integrins may not have a
bent conformation and may be constitutively extended. Small-
angle X-ray scattering (SAXS) and EM studies on the α5β1
headpiece have shown that it can adopt a closed conformation
with the hybrid domain swung in, and an open conformation with
the hybrid domain swung out (11, 14, 15) (Fig. 1A). However,
whether β1 integrins have both bent and extended conformations
like β2 and β3 integrins and the specific conformational states of
the β1 integrin ectodomain that correspond to active and inactive
states remains elusive.
A large number of activating and inhibitory antibodies are main-
stays in the β1 integrin field (14, 16–22). Some have been surmised
to be specific for conformational states, particularly of α5β1, by
indirect means such as their ability to alter ligand binding coupled
with mutagenesis interpreted with respect to the integrin αVβ3
structure (20, 23, 24). However, the lack of evidence that α5β1 has
a bent conformation and paucity of structural information on β1
integrin complexes with antibodies have limited our ability to
define the structural basis of β1 integrin biology. Among such
antibodies, only SG/19 has been structurally characterized, and its
EM and crystal structures are limited to headpiece complexes.
These have shown that whereas binding of fibronectin fragments
and RGD peptides stabilizes the open conformation of the α5β1
headpiece, binding of this inhibitory Fab stabilizes the closed head-
piece conformation (11, 14, 25).
Here we characterize the conformational states that are ac-
cessible to integrin α5β1 in the absence and presence of α5β1
Fabs, and the role of these states in α5β1-mediated adhesiveness
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to fibronectin substrates. By comparing nine function-perturb-
ing Fabs for their binding sites on specific integrin domains and
the conformational states they stabilize, we enable a large
number of previous cell biological studies on the 12 β1 integrins
to be interpreted in terms of the integrin conformational states
on cell surfaces that were stabilized. We demonstrate that acti-
vating β1 mAb can perturb the conformational equilibrium either
by stabilizing extension or headpiece opening, that α5β1 can
adopt a bent conformation, and that the extended-open and not
the bent-closed or extended-closed conformations of α5β1 medi-
ates adhesion to fibronectin.
Results
EM, Integrin α5β1, and Fibronectin.The α5β1 ectodomain was expressed
in mammalian cells using a clasped protein construct (Fig. 1B) in
which ACID and BASE coiled-coils provide the close association
between the α- and β-subunit ectodomain C termini provided in
intact cells by the associating transmembrane domains (4, 6–9, 26).
Purified clasped α5β1 was incubated with or without Fab or a fi-
bronectin fragment with Fn3 domains 7–10 (Fn3 7–10) and sub-
jected to gel filtration (Fig. 1 C and D). Peak fractions were
immediately adsorbed to electrostatically charged (glow-discharged)
carbon grids, negatively stained (and fixed) with uranyl formate, and
subjected to EM. Over 5,000 particles were picked from images
(SI Appendix, Fig. S1) and subjected to alignment, classification, and
averaging using two different algorithms (Methods). Representative
classes with good structural detail (see below) and all class averages
(SI Appendix, Figs. S2–S14) are shown.
The α5β1 ectodomain adsorbed onto EM grids in side and en
face orientations (Fig. 2 A and B, respectively). The α- and β-legs
lie together in side views and cannot be distinguished. Side-view
particles are V-shaped and comprise a globular end containing
the headpiece and a lower leg, each ∼100 Å long (Fig. 2A).
These sum to ∼200 Å, very similar to the 190–200 Å that en face,
extended particles span (Fig. 2B). Side-view α5β1 particles were
present in a range of head-to-tail distances from 110 to 200 Å
(Fig. 2 A and C). Most had head-to-tail distances of 135–150 Å
(Fig. 2A, panels 2 and 3 and Fig. 2C) and an appearance that
closely resembled compact, bent particles of four other integrins
(4, 7, 8) (Fig. 2D). Although other integrins including αIIbβ3 show
a range of V angles in the bent conformation (4), the angle is on
average greater in α5β1.
En face α5β1 was clearly extended (Fig. 2B). Although some
side-view particles were extended (Fig. 2A, panel 5), there was
little overlap in head-to-tail distance between side-view and en
face particles (Fig. 2C), suggesting that most side-view α5β1
particles are bent (Fig. 2A, panels 1–4). In en face α5β1 the two
subunits can be clearly distinguished by the larger size in the
A B
Elution Volume (mL)
No Fab
Fn3 7-10
12G10
HUTS-4
HUTS-4 + 12G10
TS2/16
TS2/16 + 9EG7
Elution Volume (mL)
A
28
0
No Fab
8E3
9EG7
N29
SNAKA51
SG/19
mAb13
mAb13 +
9EG7
7 8 9 10 11 12 13 14 15 16 17 18 7 8 9 10 11 12 13 14 15 16 17 18
0
2
4
6
8
10
12
0
2
4
6
8
10
12
14
16
A
28
0
C D
ligand
β-propeller
thigh
genu
calf-1
calf-2
TM
βI
β-tail
hybrid
PSII-EGF1
TM
I-EGF2
I-EGF3
I-EGF4
he
ad
he
ad
pie
ce
low
er
 le
g
βα α β α β Strep II
TEV
6xHis
Acidic
α-helix
Basic
α-helix
S S
extended openextended closed
bent
TEV
Fig. 1. Integrin overview and complexes for EM. (A) Three integrin con-
formational states. Dashed lines represent alternative conformations of the
flexible lower β-leg. (B) Clasped α5β1 ectodomain construct. (C and D) Gel
filtration of α5β1 alone and in complex with Fabs or Fn3 7–10. Peak integrin
fractions were subjected to EM. TM, transmembrane.
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Fig. 2. Integrin α5β1 alone and in complex with Fn3 7–10. (Scale bars, 10 nm.) (Right) Interpretative cartoons show α5, β1, and Fn3 7–10 in red, blue, and
green, respectively. Headpiece portions of en face views were cross-correlated with 2D projections of closed and open headpiece crystal structures; the
best-correlating projection and its correlation coefficient are shown below each class average. White rules show the total distance from head to tail;
yellow rules interpret the four Fn3 domains in Fn3 7–10. (A and B) α5β1 class averages; the classes represented in A are marked in C by connecting lines. (C )
All α5β1 class averages showing head-to-tail distance and particles per class, with side views in black and en face views in orange. (D) Class averages of αVβ3,
αIIbβ3, αXβ2, and αLβ2 in their bent conformation (4, 7, 8). (E ) α5β1–Fn3 7–10 complex. (F ) Closed and open headpiece crystal structures (1, 25) rendered as
described in Fig. 8.
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head of the α-subunit β-propeller domain than the β-subunit βI
domain. Thus, the α-subunit β-propeller domain and upper leg
lie to the left in Fig. 2B (Right; schematics). The α- and β-legs
tended to cross below the knees. The α-leg has larger domains
than the β-leg and was often resolved to its last domain, calf-2,
whereas the β-leg is flexible and was often “averaged out” or
faint in class averages (Fig. 2B). These leg properties resemble
those of other integrins (4, 7, 8). En face α5β1 predominantly
exhibited the closed conformation of the headpiece; the head-
piece moiety cross-correlated better with 2D projections from
closed headpiece than open headpiece crystal structures (Fig. 2B,
Lower and Methods).
α5β1 ectodomain complexes with Fn3 7–10 exclusively exhibi-
ted en face views and the extended open conformation (Fig. 2E);
the headpiece region best-correlated with 2D projections from
open headpiece integrin crystal structures (Fig. 2E, Lower). In
the open conformation, the hybrid domain swings out. This ap-
pears to result in slightly but consistently lower head-to-tail dis-
tances (Fig. 2E) than for extended-closed particles (Fig. 2B), as
the legs adopt a more curved conformation to meet at the clasp
(even though the clasp, along with the lower β-leg, is not visible).
Fn3 7–10 bound to an interface formed by the α5 β-propeller and
β1 βI domain. Fn3 7–10 adopted an extended conformation and
had a length of ∼145 Å, as seen in its crystal structure (27). Four
individual Fn3 modules were moderately resolved as globules;
these globules and their equal lengths allowed their positions to be
deduced (yellow rules, Fig. 2E). Fn3 domains 9 and 10, known to
be sufficient for binding (28), each bound the integrin. Fn3 do-
main 10 with its RGD largely laid over the βI domain, whereas
domain 9 with its synergy site appeared to partially contact the
β-propeller domain and partially extend beyond it (11, 15). Fn3
domains 7 and 8, although not essential for binding, were helpful
for visualizing and orienting the ligand in EM.
Fabs That Stabilize Extension. Four activating Fabs, 9EG7, 8E3,
N29, and SNAKA51, all stabilized extension and yielded side or
en face views of the α5β1 ectodomain with similar head-to-tail
lengths of 180–200 Å (Fig. 3). The great majority of en face views
had the closed conformation, as shown by better correlation of
their headpiece moieties with the closed conformation (Fig. 3),
whereas a small minority of class averages, at least for two of the
Fabs, displayed the open headpiece (Fig. 3 A and B, Right). 8E3
and N29 Fabs bound to the lower portion of the upper β-leg (Fig. 3
B and C), confirming previous mapping to the plexin–semaphorin–
integrin (PSI) domain (20). 9EG7 bound to the upper portion
of the lower β-leg. Individual integrin-epidermal growth factor
(I-EGF) domains were not resolved; therefore, 9EG7-binding po-
sition was measured as % of head-to-tail distance in EM. Com-
parison with distances in extended integrin ectodomain models (4)
suggested that 9EG7 bound to I-EGF2, in agreement with aboli-
tion of the epitope by a D522E mutation in I-EGF2 (19, 29).
SNAKA51 bound to the lower α5 leg at the interface between the
calf-1 and calf-2 domains (Fig. 3D), in agreement with the suffi-
ciency of a fragment containing both the calf-1 and calf-2 domains,
but not either domain alone, for SNAKA51 binding (30).
Fabs That Stabilize the Open Headpiece. The activating antibodies
12G10 and HUTS-4 stabilized the open α5β1 headpiece, as
shown by EM (Fig. 4 A and B). All class averages of the α5β1–
12G10 complex showed the en face view of α5β1 in the extended-
open conformation with 12G10 bound to the outer side of the βI
domain (Fig. 4A), consistent with epitope mapping. HUTS-4 and
α5β1 did not form a stable complex that can be purified by gel
filtration; the elution peak coincided with that of α5β1 alone (Fig.
1C). However, it formed a stable ternary complex with α5β1 and
12G10, consistent with selection of HUTS-4 for recognition of
activated integrin (16). Class averages of the ternary complex all
showed the en face view of α5β1 in the extended-open confor-
mation (Fig. 4B). HUTS-4 bound to the hybrid domain and laid
between the α5 and β1 subunits (Fig. 4B), consistent with in-
clusion in the epitope of β1 residues 355–425 (16).
TS2/16 is an unusual activating antibody that may stabilize an
open conformation of the βI domain while favoring but not re-
quiring the hybrid domain to swing out or the integrin to extend.
Most class averages of the α5β1–TS2/16 complex showed a side
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Fig. 3. Complexes of α5β1 with Fabs that stabilize extension. Representative
class averages of complexes with Fabs 9EG7 (A), 8E3 (B), N29 (C), and SNAKA51
(D). Scales, rules, cross-correlations, and cartoons are described in the legend
for Fig. 1.
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view where α5β1 exhibited both bent and extended conformations
with TS2/16 bound to the head (Fig. 4C, panels 1–5) that re-
sembled α5β1 class averages (Fig. 2 A and B). A few class aver-
ages showed a view with the head–Fab complex on the grid and
the legs missing and perhaps farther from the grid and thus not
well-stained (Fig. 4C, panels 6 and 7). En face views were absent,
and thus none of the class averages with TS2/16 alone defined
whether the headpiece was open or closed. Ternary complexes of
α5β1 with TS2/16 and the extension-specific Fab 9EG7 yielded
orientations on the grid with little overlap with TS2/16–α5β1 class
averages (SI Appendix, Figs. S10 and S11) even though 9EG7
Fab was not visualized in most ternary class averages (Fig. 4D
and SI Appendix, Fig. S11). In contrast to TS2/16–α5β1 com-
plexes, en face views were predominant in TS2/16–9EG7–α5β1
complexes. The best-resolved and most-populated en face class
averages clearly showed the extended-open conformation of α5β1
(Fig. 4D) and all class averages appeared to have the extended-
open conformation, particularly when prepared with iterative
stable alignment and clustering (SI Appendix, Fig. S11B); however,
we could not rule out the presence of a minority of extended-
closed class averages (SI Appendix, Fig. S11). The en face class
averages showed that TS2/16 bound to the βI domain (Fig. 4D),
consistent with its localization in side-view complexes (Fig. 4C)
and epitope mapping (14, 31). Saturation of α5β1 with TS2/16,
12G10, or HUTS-4 Fabs induces indistinguishable high affinity for
cyclic RGD peptide. These results and more described below
suggest that TS2/16 induces the open conformation of the βI do-
main but binds in such a way that βI domain opening (confor-
mational change in ligand-binding regions) favors but does not
require hybrid domain swing-out, namely headpiece opening as
visualized in EM (Fig. 4C).
Fabs That Stabilize the Closed Headpiece.Complexes with inhibitory
Fabs SG/19 and mAb13 showed α5β1 in the bent or extended-
closed conformation (Fig. 5). The α5β1–SG/19 complex was mostly
in the en face orientation, showing a fully extended ectodomain
with closed headpiece (Fig. 5A, panels 1–3). SG/19 bound at the
interface between the βI and hybrid domains, consistent with EM
and crystal structures (14, 25). Some class averages also showed
SG/19 Fab bound to the compact, bent conformation of α5β1 (Fig.
5A, panels 4 and 5). We made a model of an SG/19 Fab–α5β1
ectodomain complex by superimposing α5β1 headpiece–SG/19 Fab
complex and αVβ3 ectodomain crystal structures (6, 25). The
ectodomain–SG/19 Fab complex model cross-correlated well with
class averages (Fig. 5A, panels 4 and 5, Lower and Right), pro-
viding support for a compact, bent α5β1 ectodomain conformation
similar to that of αVβ3.
mAb13 clearly bound to the head of α5β1, but class averages
tended not to show the legs (Fig. 5B). Many class averages showed
the head–Fab bound to the grid with the legs perhaps farther from
the grid (Fig. 5B, panels 1–3), as shown for some TS2/16 com-
plexes (Fig. 4C, panels 6–7). Some mAb13 complex class
averages showed an en face view consistent with the closed
headpiece (Fig. 5B, panels 4 and 5). Ternary complexes with
9EG7 yielded more en face views with the α5β1 ectodomain clearly
in the extended-closed conformation and with mAb13 bound to
the βI domain (Fig. 5C), consistent with epitope mapping (31).
Functional Effects and Compatibility Between Fabs. Fab cross-
competition experiments corroborated conformational specifici-
ties of Fabs and examined competition among them for binding
sites (Fig. 6). K562 cells, which abundantly express α5β1, were
pretreated with high concentrations of one Fab or Fn3 9–10 as
“effector” or “competitor” in the absence (Fig. 6 A–I) or presence
of high concentrations of Fn3 9–10 as a second effector (Fig. 6 J–O),
and then labeled with a lower concentration of Alexa Fluor
488-labeled second Fab or Fn3 9–10. Subsequent fluorescence
flow cytometry was performed in the absence of washing to avoid
removal of the effectors/competitors. Results are informed by
findings that on K562 cells, α5β1 is >99% bent-closed; that once
extended, the extended-open conformation is more stable than
the extended-closed conformation; and that Fn3 9–10 binds
much more strongly to the extended-open than bent- or extended-
closed conformations.
Self-competition results were consistent with the predominance
of the bent conformation of α5β1 on K562 cells. The two Fabs
specific for the closed conformation, SG/19 and mAb13, each
showed robust self-competition in the absence of Fn3 9–10 (Fig.
6 G and H). Among extension-specific and open-specific Fabs,
HUTS-4, 12G10, 8E3, 9EG7, and SNAKA51 showed binding
augmented by Fn3 9–10 and good self-competition in the presence
of Fn3 9–10 (Fig. 6 K–O) but less or no self-competition in the
absence of Fn3 9–10 (Fig. 6 B–F), consistent with the importance
of Fn3 9–10 augmentation. In agreement with its ability to stabilize
βI domain opening without requiring extension or hybrid domain
swing-out, TS2/16 showed good self-competition in the absence of
Fn3 9–10 (Fig. 6I) and bound better basally to α5β1 than other
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Fig. 4. Complexes of α5β1 with Fabs that stabilize the open headpiece.
Representative class averages of complexes with Fabs 12G10 (A), HUTS-4 +
12G10 (B), TS2/16 (C), and TS2/16 + 9EG7 (D). Scales, rules, cross-correlations,
and cartoons are described in the legend for Fig. 1.
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activating Fabs, as shown by its ability to give good fluorescent
labeling at a lower concentration (0.5 nM) than other activating
Fabs (5–20 nM) (Fig. 6 A–I).
Among effectors that stabilize the open headpiece, synergy
was seen among all three, Fn3 9–10, HUTS-4, and 12G10 (Fig. 6
A–C). This is consistent with binding to three nonoverlapping
sites on the α5β1 headpiece in EM (Figs. 2E and 4 A and B).
Moreover, the open headpiece-specific effector Fn3 9–10 also
enhanced TS2/16 binding, consistent with TS2/16 specificity for
the open conformation of the βI domain (Fig. 6I). Among ef-
fectors that induce extension, synergy was seen among 8E3,
9EG7, and SNAKA51, and also with Fn3 9–10 (Fig. 6 A and D–
F). Synergy was also seen between effectors that stabilized
headpiece opening and extension. Open headpiece-specific Fab
12G10 stabilized binding of extension-specific Fabs 8E3, 9EG7,
and SNAKA51 (Fig. 6 D–F). In contrast, the weaker, opening-
reporting (16) Fab HUTS-4 more modestly stabilized binding of
SNAKA51 and 9EG7 and lacked effect on 8E3 (Fig. 6 D–F).
Conversely, extension-specific Fabs 8E3, 9EG7, and SNAKA51
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Fig. 5. Complexes of α5β1 with Fabs that stabilize the closed headpiece.
Representative class averages of SG/19 (A), mAb13 (B), and mAb13 + 9EG7
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Fig. 6. Competition or synergy in binding of Fabs and fibronectin. K562 cells
were incubated with high concentrations of Fabs or Fn3 9–10 (Fn) effectors for
90 min (labeled on left axis) without (A–I) or with (J–O) 15 μM Fn, and then
with a second Alexa Fluor 488-labeled Fab or Fn reporter at the concentrations
shown (Top) for 30 min and subjected to immunofluorescence flow cytometry
without any washing. Effector concentrations are (A–I) 3 μM for TS2/16 and
12G10; 6 μM for 8E3, 9EG7, SNAKA51, SG19, and mAb13; 15 μM for HUTS-4
and Fn; and (J–O) 20 nM for TS2/16 and 12G10; 40 nM for 8E3, 9EG7, and
SNAKA51; and 100 nM for HUTS-4. Error bars show standard deviation.
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all enhanced binding of the open headpiece-specific Fab 12G10
(Fig. 6C) and of Fn3 9–10 (Fig. 6A).
Fabs that destabilized conformations recognized by other mAbs
also showed competition. Thus, extension-specific Fabs SNAKA51,
9EG7, and 8E3 and open headpiece-specific Fab HUTS-4 all
inhibited mAb13 and SG/19 binding (Fig. 6 G and H).
Competition was also evident among Fabs that bind to over-
lapping epitopes; many of the open headpiece-specific and closed
headpiece-specific Fabs compete by binding to overlapping epi-
topes on the βI domain in addition to binding to alternative
conformations. The activating Fabs TS2/16 and 12G10 and in-
hibitory Fab mAb13 were raised in mice or rats against human β1
integrins. These and many other β1 integrin function-modulating
antibodies are specific for human residues at positions 207, 208,
211, and 218 in the βI domain; indeed, introduction of these four
human residues into the chicken β1 integrin subunit is sufficient
for epitope reconstitution (14, 31, 32). Thus, cross-blocking of
activating TS2/16 and 12G10 and closed headpiece-specific
mAb13 Fabs (Fig. 6 C, H–J, and L) is explicable by binding to this
epitope. Fab SG/19 binds to an epitope that includes residues 151,
154, and 155 at the C-terminal end of the α1-helix, which are
immediately adjacent to residues 207–211 at the beginning of the
α2-helix in the βI domain. The close spatial proximity of the SG/19
and mAb13 epitopes is consistent with their cross-blocking (Fig. 6
G and H) (14), and similar proximity of the SG/19 epitope to the
TS2/16 and 12G10 epitopes likely explains cross-blocking among
these Fabs (Fig. 6 C,G, and I). When TS2/16 prebinding stabilized
the open βI domain conformation it competed with SG/19 binding
(Fig. 6G), whereas when SG/19 prebinding stabilized the closed
conformation it failed to compete with TS2/16 binding (Fig. 6I).
This lack of reciprocity might mean that the epitopes recognized
by these two Fabs overlap in the open βI domain but not the
closed βI domain conformation.
In the presence of Fn3 9–10, open headpiece-specific Fab
HUTS-4 and extension-specific Fab 8E3 cross-competed with one
another (Fig. 6 K and M). These Fabs bind to the hybrid and PSI
domains, respectively, which are adjacent in the upper β-leg, and
simultaneous Fab binding might be forbidden by steric overlap.
Fab HUTS-4 also competed with SNAKA51 in the presence of
Fn3 9–10 (Fig. 6 K and O). Although these Fabs bind to different
domains in different integrin subunits, when bound to β1, HUTS-4
Fab extends toward α5 (Fig. 4B) and might sterically overlap with
SNAKA51 Fab in the extended-open conformation.
The functional relevance of the three conformational states of
α5β1 was characterized by measuring the effect of Fabs on ad-
hesion of K562 cells to substrates precoated with Fn3 7–10 or
plasma fibronectin. Basal binding to the two substrates by K562
cells was low in Mg2+/Ca2+ and much greater in Mn2+ (Fig. 7).
Extension-specific Fabs 8E3, 9EG7, N29, and SNAKA51; open
headpiece-specific Fabs 12G10 and HUTS-4; and open βI
domain-specific Fab TS2/16 all enhanced adhesion strongly.
Closed headpiece-specific Fabs SG/19 and mAb13 completely
suppressed activation by Mn2+ (Fig. 7).
To address the mechanism of activation by extension-specific
Fabs, we used combinations of extension-specific and closed
headpiece-specific Fabs that showed no interference with one
another in cross-competition assays (Fig. 6 and Table 1), SNAKA51
plus SG/19 and 9EG7 plus mAb13 (Fig. 7). In each case, the
closed headpiece-specific Fab completely suppressed the acti-
vating effect of the extension-specific Fab, demonstrating that
α5β1 ectodomain extension alone is not sufficient for adhesion
and that the open headpiece conformation is required. In con-
trast, combinations of extension-specific and open headpiece-
specific Fabs were activating. Taken together, these results
demonstrate that the bent-closed and extended-closed states
of integrin α5β1 are nonadhesive, whereas the extended-open
conformation is highly adhesive. Furthermore, the low basal adhe-
siveness of K562 cells suggests the presence of little extended-open
α5β1 on the cell surface.
Discussion
Our major finding is that integrin α5β1 has three conformational
states including a bent-closed state. Furthermore, we demonstrate
that the bent-closed and extended-closed states are nonadhesive
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Table 1. Antibody specificity and interaction with other antibodies and fibronectin
Number* Name Species Domain Function
Conformational
specificity ⊘† +‡ −§
1 8E3 Mouse PSI Activating Extended 5 3, 4, 6, 10
2 N29 Mouse PSI Activating Extended
3 9EG7 Rat I-EGF2 Activating Extended 1, 4, 5, 6, 10
4 SNAKA51 Mouse Calf-1/Calf-2 Activating Extended 5 1, 3, 6, 10
5 HUTS-4 Mouse hybrid Activating Open headpiece 1, 4 3, 6, 10
6 12G10 Mouse βI Activating Open headpiece 7, 8, 9 1, 3, 4, 5, 10 9
7 TS2/16 Mouse βI Activating Open βI 6, 8 10
8 mAb13 Rat βI Inhibitory Closed headpiece 6, 7, 9 1, 3, 4, 5, 10
9 SG/19 Mouse βI/hybrid Inhibitory Closed headpiece 6, 8 1, 3, 4, 5, 6, 7, 10
10 Fibronectin βI/β-Propeller Ligand Open headpiece 1, 3, 4, 5, 6
*Antibody number used in the three right-hand columns.
†Numbers of antibodies that inhibit binding, presumably by competing for binding.
‡Numbers of antibodies that enhance binding, presumably by affecting conformational equilibria.
§Numbers of antibodies that inhibit binding, presumably by affecting conformational equilibria.
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and the extended-open state is adhesive on K562 cells. Basally,
K562 cells are nonadhesive. These results correlate with our
EM observations that α5β1 ectodomain preparations pre-
dominantly populate the bent-closed conformation and that
complex formation with Fn3 9–10 induces the extended-open
conformation. By defining which of the three conformational
states of α5β1 that nine different function-perturbing antibodies
stabilize (Table 1), we enable extensive structure–function
correlations. Previously, many of these antibodies have been
inferred to be conformation-specific by their effects on ligand
binding, mapping to regions known to shift conformation in
other integrins, effects of conformation-constraining disulfide
bonds, and reference to conformations defined in other integ-
rins (16, 20, 29). Such methods have been used to show that
α5β1 can be stabilized in a bent conformation with a disulfide
bond introduced between the calf-2 and β-tail domains and is
extended and active in focal contacts but bent in other locations
on the cell surface; however, functional differences between
extended-closed and extended-open conformations were not
resolved (29). Although previous studies have been helpful, the
paucity of information on conformational change in β1 integrins
compared with β2 and β3 integrins has been emphasized even by
laboratories that have made leading contributions to charac-
terizing β1 integrin antibodies (22, 29).
The β1 integrin subfamily has many more distinct αβ hetero-
dimers (12) than the β2 (4) or β3 (2) integrin subfamilies. Work
with β1 integrins has shown heterogeneity in their ability to be
activated and has suggested subunit-dependent differences
among integrins (19). Furthermore, it has been proposed that
there are only two types of integrin activation-dependent anti-
bodies, (i) ligand-mimetic antibodies and (ii) cation and ligand-
induced binding-site antibodies (33). Our findings show that the
latter consist of distinct groups, those (i) that stabilize the ex-
tended conformation and (ii) that stabilize the open conforma-
tion—of the βI domain only or of both the βI and hybrid
domains. Despite speculation that different subfamilies of
integrins may differ in activation mechanism or conformation,
the three overall global conformational states of α5β1 seen here
with EM—bent-closed, extended-closed, and extended-open—
are similar to those of αVβ3, αIIbβ3, αXβ2, and αLβ2 (4, 7–9).
Characterization of function-perturbing β3 integrin antibodies in
EM is limited (34), and the extended-open conformation has
been induced by ligand binding (7, 10, 12) rather than correlated
with function using antibodies as done here for α5β1. The ex-
tended-open conformation has been shown to be the only ad-
hesive and high-affinity conformation of β2 integrins using sets of
Fabs analogous to those used here (9, 13); however, the corre-
lation is less direct than demonstrated here because β2 integrins
bind ligand through an αI domain inserted into their α-subunits.
αI domain conformation cannot be visualized in EM, and con-
formational change must be transmitted to the αI domain from
the βI domain in the headpiece.
Despite global similarities among the three overall confor-
mational states possessed by β1, β2, and β3 integrins, there are
notable differences among these integrins in their behavior in
negative-stain EM and among the antibodies that define β1, β2,
and β3 integrin conformational states. The strength of negative-
stain EM is that particles become oriented; certain orientations
selectively adsorb to the negatively charged carbon grid (perhaps
those that present larger areas for adsorption), and this limited
set of orientations makes it easier to distinguish alternative
conformations from alternative orientations (in projection av-
erages) than in vitreous ice with cryo-EM, where orientation is
usually random (35). However, in contrast to αVβ3, αIIbβ3, and
αXβ2, which when extended largely adsorbed in en face views,
α5β1 largely adsorbed in side views [similar to αLβ2 (8)], in which
the α- and β-subunits and their conformations were difficult to
distinguish. Perhaps related to this difference in adsorption, or
perhaps because the compact form of the bent conformation is
less stable in α5β1 than in these other integrins, it exhibited a
wide range of bending angles, ranging from a compact con-
formation resembling the compact, bent conformations of
αVβ3, αIIbβ3, αXβ2, and αLβ2 (4, 7, 8) to fully extended. A large
number of EM grids and Fab complexes were examined for
α5β1 and each was subjected to two independent methods of
particle classification and averaging that gave similar results
(SI Appendix, Figs. S2–S14). The conclusion that α5β1 exists in
a bent conformation is also supported by class averages of SG/
19 Fab–ectodomain complexes that show a compact, bent
conformation similar to that of the αVβ3 ectodomain modeled
bound to SG/19 Fab.
How do the Fabs studied here stabilize particular conforma-
tional states? Models of the bent conformation of α5β1 made
using bent conformations of αVβ3 and αIIbβ3 suggest that exten-
sion-specific Fabs bind to epitopes that are buried in headpiece–
tailpiece or α-leg–β-leg interfaces in the bent conformation.
Integrins are likely to equilibrate rapidly among their confor-
mational states; extension-specific Fabs would bind when the
integrin was extended, and then trap (stabilize) it in that state.
9EG7 recognizes a single species-specific difference in the β1
I-EGF2 domain, Asp-522 in human and mouse, which is Glu in rat
(29). The equivalent residue in the bent conformation of αIIbβ3 is
surrounded and protected from Fab by the α-subunit thigh and
calf-1 domains and β-subunit PSI and I-EGF1 domains (Fig. 1A)
(4). These domains move away from I-EGF2 during extension
and thus permit 9EG7 binding. Extension-specific KIM127 Fab
to β2 integrins similarly binds to I-EGF2 (8). 8E3 and N29 Fabs
bind to the PSI domain. The bend at the β-knee between the
upper and lower β-legs places the PSI domain between I-EGF1
in the upper leg and I-EGF2 and I-EGF3 in the lower leg. Leg
extension removes the proximity of I-EGF2 and I-EGF3 to PSI,
and thus permits binding of antibodies specific for the extended
conformation to PSI (Fig. 1A). SNAKA51 binds to the interface
between the calf-1 and calf-2 domains in the lower α-leg, near
both the lower β-leg and the headpiece in the bent conformation.
Thus, SNAKA51 is predicted to bind to a site that is exposed in
the extended but not bent conformations.
Fabs that stabilize the closed headpiece bind to regions of
the closed headpiece that differ in conformation from the open
headpiece. SG/19 recognizes a single species-specific residue,
Thr-82, in a hybrid domain loop that only becomes ordered
when bound to SG/19 (Fig. 8A) (25, 36). SG/19 simultaneously
recognizes human–mouse invariant residues at the end of the
α1-helix in the βI domain, and thus recognizes an orientation
between the hybrid and βI domains present only in the closed
conformation. Similarly, 7E4 binds to hybrid domain residue
V385 in this interface and stabilizes the closed conformation of
this interface in β2 integrins (Fig. 8A) (9).
The β1 subunit is unusually conserved between mouse and hu-
man among integrins, and many function-perturbing antibodies
recognize species-specific differences at βI domain α2-helix resi-
dues 207, 208, 211, and 218 (14, 31, 32); however, the α2-helix
moves little in integrin allostery (Fig. 8). Instead, the α2-helix
neighbors the α1-helix, which in turn neighbors the α7-helix.
Movements of the α1- and α7-helices transmit conformational
change in the βI domain between its ligand-binding site and in-
terface with the hybrid domain (Fig. 8) (12). α1-Helix side chains
form important coordinations to the metal ion dependent adhe-
sion site (MIDAS) and adjacent to MIDAS (ADMIDAS) metal
ions that alter in the high-affinity state, and pistoning of the βI
domain α7-helix C terminus toward the hybrid domain causes
pivoting at the N-terminal connection of the βI domain to the
hybrid domain. In other words, headpiece opening comes about
because the βI domain is inserted into the hybrid domain, and
pistoning at one of the two connections between these domains
causes pivoting at the other.
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At the adjacent α7-, α1-, and α2-helices in open and closed β3
structures, backbone Cα atoms differ 4.7–9 Å at the α7-helix,
4–6.5 Å at the α1-helix, and only 0.7–2.7 Å at the equivalents of
residues 207, 208, 211, and 218 in the α2-helix (12) (Fig. 8). Thus,
the closed headpiece-specific Fab mAb13 and the open head-
piece-specific Fabs 12G10 and TS2/16 likely become conforma-
tion-specific by recognizing not only species-specific residues in
the α2-helix but also conformation-specific locations of residues in
the adjacent α1-helix. Among these three Fabs, the en face views
with 12G10 suggest it binds more toward the α1-helix because it
projects from the side of the headpiece similarly to SG/19, which
binds the α1-helix, whereas the lack of clear views of the main
plane of the headpiece with mAb13 and TS2/16 suggests they
interfere with the binding of the main plane of the headpiece to
the grid by projecting more orthogonally and binding more toward
the α3-helix (see species-specific residue locations in Fig. 8).
HUTS-4 binds to the inner, α-subunit proximal face of the hy-
brid domain and stabilizes its open conformation. βI domain in-
sertion splits the hybrid domain into N- and C-terminal portions
(colored blue and red, respectively, in Fig. 8). The C-terminal
sequence forms the inner, α-subunit proximal half of the hybrid
domain, consistent with mapping of the species specificity of
HUTS-4 to this segment (16). In the closed conformation, this
face of the hybrid domain contacts a long β-ribbon in the β-pro-
peller W5 β2-β3 loop (Fig. 8A), explaining why HUTS-4 is specific
for the open conformation. MEM148 to β2 integrins recognizes
the P374S substitution in the C-terminal segment of the hybrid
domain (Fig. 8B) to similarly stabilize the open conformation (9).
In the high-affinity conformational state of α5β1, the ligand-
binding site at the β-propeller and βI domain interface is nor-
mally linked through α7-helix motion to headpiece opening,
visualized in EM by hybrid domain swing-out, as shown here with
Fn3 7–10 and Fabs 12G10 and HUTS-4 bound to the ectodo-
main. TS2/16 appears not to require hybrid domain swing-out,
but nonetheless appears to favor hybrid domain swing-out. In
EM, TS2/16–α5β1 complexes resembled those of α5β1 alone.
Most ternary complexes of TS2/16 and α5β1 with the extension-
stabilizing Fab 9EG7 showed en face views with the open
headpiece, although we could not rule out the presence of a
minority of closed headpieces (SI Appendix, Fig. S11), in contrast
to 9EG7 complexes with α5β1 alone, in which the closed head-
piece predominated. Immunofluorescence flow cytometry showed
cooperation between Fn and TS2/16 binding; however, cooper-
ation with HUTS-4 or extension-stabilizing Fabs was not seen,
again suggesting that TS2/16 does not require hybrid domain
swing-out. Linkage of Fn3 7–10 and 12G10 but not TS2/16 binding
to headpiece opening also correlates with regulation by divalent
cations of their binding (20). Saturation binding of TS2/16, 12G10,
and HUTS-4 Fabs induces nearly identical intrinsic, high affinities
for cyclic RGD peptide, suggesting they stabilize identical confor-
mations of the ligand-binding site in the βI domain.
These findings suggest that TS2/16 might enable a “cocked”
conformation of the βI domain in which the α1-helix moves,
enabling high-affinity ligand binding, despite the absence of
movement or alteration of α7-helix movement from the pathway
it normally takes in headpiece opening. A cocked conformation
was seen in a crystal structure of αXβ2 in which the “internal li-
gand” of the αI domain bound to the βI domain MIDAS and
relayed allostery between the αI and βI domains, despite
the absence of α7-helix motion and presence of a bent-closed
ectodomain conformation (37), as seen here in EM with bound
TS2/16. In each case, the cocked conformation may represent a
metastable intermediate, namely, in energy landscape parlance, a
local energy minimum lying between two global, lower-energy
minima representing the open and closed headpiece conforma-
tions. In this scenario, TS2/16 would be able to bind both the
cocked and open conformations but not the closed conforma-
tion. A cocked conformation, with the βI domain open around
the ligand-binding site but the hybrid domain not swung out, may
be on the pathway between the closed and open conformations.
However, this cocked conformation is not seen under physiologic
ligand-binding conditions, because all class averages with Fn3 7–10
had extended-open conformations (SI Appendix, Fig. S3).
The results with TS2/16 force us to distinguish between βI domain
opening and headpiece opening. We cannot visualize βI domain
opening by negative-stain EM. Usually βI domain opening is linked
to headpiece movement by C-terminal pistoning of the βI domain
α7-helix, which forces the hybrid domain to pivot about its other
connection to the βI domain and to swing out, which is readily ap-
parent in EM as the “open headpiece.”When α5β1 is extended, TS2/
16 complexes exhibit the open headpiece conformation. Thus, TS2/
16 stabilizes the open conformation of the βI domain and is distinct
from Fabs that bind to the βI domain and stabilize the closed con-
formation of the βI domain such as mAb13, which show the ex-
tended-closed conformation in en face views.
Evolution has resulted in great variation in the types of con-
formation-specific, species-specific antibodies that are available for
different integrin β-subunits. In integrin β1 the α1- and α7-helices
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have essentially invariant sequences in mammals and vertebrates,
respectively, whereas in integrin β2 the α1- and α7-helices each
have two mouse–human differences that elicit conformation-spe-
cific antibodies (Fig. 8) (38, 39). Antibodies to these epitopes not
only directly bind the elements that communicate allostery between
the βI domain and headpiece but also project from the side of the
headpiece (9), making recognition of headpiece conformation in
EM easier with β2 than β1 integrins. The integrin β3 subunit also
has little variation in α1- and α7-helix sequence in mammals,
except near the MIDAS, where antibodies would likely block the
ligand-binding site and therefore not be allosteric. There are
currently no known open headpiece-specific or closed headpiece-
specific allosteric antibodies to β3 integrins; β3 integrin ligand-
induced binding-site antibodies appear to be extension-specific (34).
In summary, we have shown that integrin α5β1 possesses at least
three distinct global conformational states. We have defined the
states stabilized by nine function-perturbing antibodies widely
used in the β1 integrin field. Basally under conditions in which the
bent-closed conformation likely predominates, α5β1 on K562 cells
is not adhesive for fibronectin. With Fabs to stabilize extension
and the closed or open states of the βI domain and the headpiece,
we demonstrated that the extended-open conformation and not
the extended-closed conformation of α5β1 on K562 cells is adhe-
sive for fibronectin. Among the remaining important questions is
how β1 integrins with different α-subunits differ in the set points
for their conformational equilibria on cell surfaces (19).
Methods
Integrin α5β1 Glycoprotein. DNA constructs were exactly as described pre-
viously, except for replacement of αX and β2 with α5 and β1, respectively (8).
The α5 ectodomain with signal peptide and residues F1–Y954 with a C-ter-
minal tobacco etch virus (TEV) protease site, acidic coiled-coil with a cysteine
for disulfide-bond formation, and Strep II tag was inserted into the XbaI and
AgeI sites of pcDNA3.1/Hygro(−). The β1 ectodomain cDNA with signal
peptide and mature residues Q1–D708 with a C-terminal TEV site, basic
coiled-coil with a cysteine, and hexahistidine tag was subcloned into BamHI
and XbaI sites of pEF1-puro. Stable HEK293S GnTI−/− transfectants were se-
lected. Purification was as for the α5β1 headpiece (36), except for omission of
TEV cleavage. Sources of SG/19 and TS2/16 (14) and 12G10, 8E3, SNAKA51,
HUTS-4, and 9EG7 (29) were as described. N29 (40) and mAb13 (41) hy-
bridomas were kind gifts of J. Wilkins (University of Manitoba, Winnipeg,
MB) and K.M. Yamada (NIH, Bethesda, MD), respectively. IgGs were purified
by protein G affinity, and Fab fragments were prepared by papain digestion.
Fibronectin Fragments. Human Fn3 7–10 (mature residues 1,142–1,509), Fn3
9–10 (mature residues 1,326–1,509 with an N-terminal His6 tag), or the Fn3
9–10 Ser-1417 to Cys mutant were expressed and purified from Escherichia
coli as described (26), except His tag affinity purification was used for Fn3 9–10.
Fn3 7–10 was used in EM because domains 7 and 8 helped localize the α5β1-
binding site in Fn3 domains 9 and 10. Fn3 9–10 was obtained in higher yield
and could easily be concentrated highly, and was therefore used in Fab cross-
competition assays. The Fn3 9–10 S1417C mutant was specifically labeled at
C1417 with Alexa Fluor 488 C5maleimide (Thermo Fisher Scientific) for use as a
reporter in Fab cross-competition assays; Fn3 7–10 has a native unpaired Cys
residue (C1201) in Fn3 domain 7.
EM. α5β1 (100 μg/mL) alone or with five molar equivalents of Fab (100 μg/mL)
or Fn3 7–10 (80 μg/mL) in 20 mM Tris buffered saline (pH 7.4) supplemented
with 1 mM CaCl2, 1 mMMgCl2 (α5β1 and Fab complexes) or with 1 mMMnCl2
(Fn3 7–10 complex) was held for 20 min at 21 °C and then subjected to
Superdex 200 gel filtration in the same buffer. Peak fractions were applied
to glow-discharged grids, stained with 0.75% (wt/vol) uranyl formate (8),
and imaged with an FEI Tecnai T12 microscope and Gatan 4K×4K CCD
camera at 67,000× magnification (1.68 Å pixel size) and -1.5 μm defocus.
Well-separated particles of reasonable sizes for integrins were interactively
picked using EMAN2 (42) as illustrated in SI Appendix, Fig. S1. Class averages
were calculated by (i) multireference alignment followed by K-means clus-
tering using SPIDER (9, 43, 44) and also (ii) iterative stable alignment and
clustering using SPARX (45). Cross-correlations were with 2D projections
generated at 4° intervals from 20-Å-filtered α5β1 closed crystal structures,
models of the open headpiece made by substituting the open β3 subunit
from Protein Data Bank (PDB) ID code 2VDR for the β1 subunit in PDB ID
code 3VI3, or by superposition of SG/19-bound α5β1 in PDB ID code 3VI3 onto
the αVβ3 ectodomain in PDB ID code 4G1E.
Cell Adhesion. Microtiter plate wells adsorbed with Fn3 7–10 or plasma fi-
bronectin (10 μg/mL in 50 μL) at 4 °C overnight were blocked with 3% (wt/vol)
BSA in PBS. K562 cells (kept in PBS with 0.5% BSA) were fluorescently labeled
with 2′,7′-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein, acetoxymethyl ester
(BCECF AM) at 37 °C for 30min andwashedwith 5mMEDTA. Cells (2×106 permL,
50 μL) in PBS with 1% BSA and 25 μg/mL Fabs in either 1 mM CaCl2/1 mM
MgCl2, 1 mM MnCl2, or 10 mM EDTA were incubated at 37 °C for 1 h and
washed thrice. Adherence was measured as the ratio of fluorescence intensity
post and before wash.
Fab Cross-Competition. K562 cells (2 × 106 per mL) in phenol red-free L15
medium with 1% BSA were incubated with high, specified concentrations of
unlabeled Fabs with or without Fn3 9–10 at 21 °C for 90 min, mixed with
lower, specified concentrations of Alexa Fluor 488-labeled Fabs or Fn3 9–10
for 30 min, and then without washing subjected to immunofluorescence
flow cytometry. Mean fluorescence intensity (MFI) was measured.
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